Methotrexate prolonged the shedding of replicable SARS-CoV-2 with re-increased antigens in a rheumatoid arthritis patient-Reference-Cited by-同舟云学术

Methotrexate prolonged the shedding of replicable SARS-CoV-2 with re-increased antigens in a rheumatoid arthritis patient

Published:2024-09-04 Issue: Volume: Page:1-3
ISSN:0300-9742
Container-title:Scandinavian Journal of Rheumatology
language:en
Short-container-title:Scandinavian Journal of Rheumatology

Author:

Takatani A¹,Kobayashi T²,Iwamoto N¹³,Aramaki T¹,Terada K¹,Izumikawa K⁴,Ngwe Tun MM⁵,Morita K⁵,Ueki Y¹,Kawakami A³,Eguchi K¹

Affiliation:

1. Rheumatic Disease Center, Sasebo Chuo Hospital, Sasebo, Japan

2. Department of Respiratory Medicine, Sasebo Chuo Hospital, Sasebo, Japan

3. Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

4. Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

5. Department of Virology, Institute of Tropical Medicine, Dejima Infectious Disease Research Alliance, Nagasaki University, Nagasaki, Japan

Funder

any bodies

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/03009742.2024.2361994

Reference8 articles.

1. The evaluation of a rapid microfluidic immunofluorescence antigen test in detecting the infectiousness of COVID-19 patients

2. Duration of SARS‐CoV‐2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID‐19

3. Duration of SARS-CoV-2 RNA positivity from various specimens and clinical characteristics in patients with COVID-19: a systematic review and meta-analysis

4. Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis

5. The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models